Description
Capecitabine, marketed under the brand name Xeloda, It is an prescription medication that has been approved by the FDA in 2001 as a first-line therapeutic to treat patients with metastatic colorectal cancer.
What is Opdivo (Nivolumab) ?
Nivolumab is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of: Melanoma, Non-Small Cell Lung Cancer (NSCLC), Non-Small Cell Lung Cancer (NSCLC), Classical Hodgkin Lymphoma (cHL), Squamous Cell Carcinoma of the Head and Neck (SCCHN), Urothelial Carcinoma, Colorectal Cancer, Hepatocellular Carcinoma (HCC), Esophageal Squamous Cell Carcinoma (ESCC), Infusion-related reactions, Complications of allogeneic HSCT, Embryo-Fetal toxicity, Treatment of patients with multiple myeloma with a PD-1 or PD-L1 blocking antibody in combination with a thalidomide analogue plus dexamethasone is not recommended outside of controlled clinical trials.
How to order approved “Opdivo (Nivolumab) for injection” Medicine?
Opdivo (Nivolumab) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing Opdivo and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
